Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study

OBJECTIVE: To compare the risk of cardiovascular events between sodium glucose cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors among people with type 2 diabetes in a real world context of clinical practice. DESIGN: Multi-database retrospective cohort study using a pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Filion, Kristian B, Lix, Lisa M, Yu, Oriana HY, Dell’Aniello, Sophie, Douros, Antonios, Shah, Baiju R, St-Jean, Audray, Fisher, Anat, Tremblay, Eric, Bugden, Shawn C, Alessi-Severini, Silvia, Ronksley, Paul E, Hu, Nianping, Dormuth, Colin R, Ernst, Pierre, Suissa, Samy, Hemmelgarn, Brenda R, Quail, Jacqueline, Chateau, Dan, Paterson, J Michael, LeLorier, Jacques, Levy, Adrian R, Ernst,, Pierre, Platt,, Robert W, Sketris, Ingrid S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009082/
https://www.ncbi.nlm.nih.gov/pubmed/32967856
http://dx.doi.org/10.1136/bmj.m3342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009082/
https://www.ncbi.nlm.nih.gov/pubmed/32967856
http://dx.doi.org/10.1136/bmj.m3342

Ejemplares similares